ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,237, issued on March 25, was assigned to Purdue Pharma LP (Stamford, Conn.).
"Tinostamustine for use in treating sarcoma" was invented by Thomas Jorg Mehrling (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided tinostamustine or a pharmaceutically acceptable salt thereof for use in the treatment of sarcomain a patient in need thereof."
The patent was filed on Feb. 13, 2023, under Application No. 18/108,736.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=P...